Abbas Dehghan MD PhD FESCis a medical doctor and an epidemiologist. He studied Epidemiology at Netherlands Institute for Health Sciences (NIHES) and worked with the Rotterdam Study at the department of epidemiology, Erasmus Medical Center, the Netherlands for more than 10 years. In 2016, he joined the Department of Epidemiology and Biostatistics at Imperial College London as a reader in cardiometabolic disorders.
Dr Dehghan is a member of the steering committee of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium and has led or been involved in many genome-wide association (GWAS) studies. He has been co-PI of COMBI-BIO, an FP7 EU funded project on the metabolomics of atherosclerosis.
Dr Dehghan is working on the genetics of omics, in particular metabolomics, and applying Mendelian Randomisation approach to investigate causal determinants of complex traits and diseases including cardiometabolic disorders, dementia and cancers.
Since January 2020, Dr Dehghan is the director of postgraduate research at the school of public health.
et al., 2021, Meta-analysis of epigenome-wide association studies of carotid intima-media thickness., Eur J Epidemiol
et al., 2021, Epicardial fat volume and the risk of cardiometabolic diseases among women and men from the general population, European Journal of Preventive Cardiology, ISSN:2047-4873
et al., 2021, Urate, blood pressure and cardiovascular disease: evidence from Mendelian randomization and meta-analysis of clinical trials, Hypertension, Vol:77, ISSN:0194-911X, Pages:383-392
et al., 2020, A Mendelian randomization of γ′ and total fibrinogen levels in relation to venous thromboembolism and ischemic stroke, Blood, Vol:136, ISSN:0006-4971, Pages:3062-3069
et al., 2020, Accelerated MRI-predicted brain ageing and its associations with cardiometabolic and brain disorders, Scientific Reports, Vol:10, ISSN:2045-2322